AUG 31, 2018 Business

Machavert closes A round financing of $4.5m

Machavert has closed their A Round of financing of ~$4.5m by raising $2.2 million in the second…

JUL 31, 2018 Business

Machavert’s Annual General Meeting

Machavert’s Shareholders Annual General Meeting took place on June 27th in Prague, Czech…

JUL 26, 2018 People

Leading immuno-oncologist Norman Michael Greenberg joins Science Advisory Board of Machavert

We are very happy to welcome Dr. Norman Michael Greenberg to our Science Advisory Board (SAB).

MAR 6, 2018 Science

We welcomed Prof. David Brautigan to his first meeting at our Science Advisory Board

David travelled from Charlottesville, Virginia to visit Machavert headquarters at Anschutz…

FEB 8, 2018 Business

Shareholders General Meeting

Machavert’s Shareholders General Meeting took place on February 6 in Prague, Czech Republic.

FEB 1, 2018 People

Dr. Neal Goodwin joins Machavert as Chief Science Officer

Machavert is excited to introduce Dr. Neal Goodwin, Ph.D. as the Chief Science Officer who will…

JAN 17, 2018 People

Machavert welcomes Dennis R. Voelker as a member of Science Advisory Board

Dennis R. Voelker is Professor in the Department of Medicine and Director of Research, Pulmonary…

DEC 11, 2017 People

Meet Dan Theodorescu of the recently established Science Advisory Board

Dan Theodorescu is the Director of the NCI designated Comprehensive Cancer Center at the…

NOV 24, 2017 People

Prof. Dan Theodorescu of the Machavert’s SAB recognized for his groundbreaking research

Dan Theodorescu from our Science Advisory Board was recently recognized by the University of…

Page 1 of 212